BBBen Bepouka

Ben Bepouka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ben Bepouka has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Hippolyte Situakibanza

    Office of Research on Infectious Diseases and Global Health, Infectious Diseases Unit, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa 13541, DR Congo; Infectious and Tropical Diseases Unit, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, DR Congo

    11 shared publications
  • Murielle Longokolo

    Office of Research on Infectious Diseases and Global Health, Infectious Diseases Unit, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa 13541, DR Congo; Infectious and Tropical Diseases Unit, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Kinshasa, DR Congo

    9 shared publications
  • Marcel Mbula

    Infectious and Tropical Diseases Service, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo

    8 shared publications
  • Madone Mandina

    Infectious and Tropical Diseases Service, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo

    7 shared publications
  • Nadine Mayasi

    Infectious and Tropical Diseases Service, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo

    7 shared publications
  • Ossam Odio

    Infectious and Tropical Diseases Service, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo

    6 shared publications

Latest Publications

  • Open Access

    Exploring the Potential Contribution of Climate-Informed Research to Future Ebola Preparedness in Central Africa

    by Sandra Ndaka Sumbu, Ben Bepouka

    The ongoing 2026 Bundibugyo ebolavirus outbreak in eastern Democratic Republic of the Congo highlights the continued vulnerability of Central Africa to recurrent Ebola emergence. This outbreak emerged less than six months after the previous one ended, appears to represent one of the shortest documented inter-epidemic intervals in the Democratic Republic of the Congo based on currently available outbreak reports. Current surveillance systems remain largely reactive, focusing on the detection of human cases after zoonotic spillover has occurred. While strengthening health systems, diagnostic capacity, and early case detection remains the cornerstone of Ebola preparedness, growing research suggests that environmental and climatic information may eventually contribute to a broader understanding of spillover risk within a One Health framework. However, current evidence remains insufficient to identify validated environmental indicators or operational thresholds capable of predicting Ebola spillover events. Recent modeling studies have demonstrated that environmental drivers of Ebola emergence remain highly context-dependent and cannot yet support operational early warning systems. This commentary argues that continued research integrating environmental monitoring, remote sensing, ecological observations, and epidemiological data may improve understanding of Ebola emergence and eventually contribute to future preparedness strategies. Rather than proposing climate-informed preparedness approaches as an operational prediction tool, we emphasize its potential as a complementary research priority requiring further validation before any operational implementation.


  • Open Access

    Healthcare-associated transmission and early IPC system vulnerabilities during the 2026 Bundibugyo Ebola outbreak in eastern Democratic Republic of the Congo

    by Ben Bepouka, Mardoche Kafua

    The 2026 Bundibugyo Ebola outbreak in eastern DRC highlighted important early infection prevention and control (IPC) challenges, including healthcare-associated transmission, healthcare worker infections, unsafe triage systems, limited isolation capacity, and shortages of IPC supplies. This commentary argues that pathogen-specific preparedness may remain insufficient in settings characterized by diagnostic uncertainty and proposes an “IPC-first” outbreak response framework based on rapid syndromic IPC activation before definitive laboratory confirmation becomes available.


  • Open Access

    Factors influencing pre-exposure prophylaxis adherence among female sex workers in Kinshasa, Democratic Republic of the Congo: a prospective cohort study

    by Ben Bepouka, William M. Miller, Antoinette Tshefu, Pierre Buekens

    Female sex workers (FSWs) in the Democratic Republic of the Congo (DRC) bear a disproportionately high burden of HIV infection. Daily oral pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy, but its public health impact depends on sustained adherence. Evidence of PrEP adherence among FSWs in the DRC remains limited. This study assessed PrEP adherence over time and identified factors associated with adherence among FSWs in Kinshasa. We conducted a 6-month prospective cohort study among 120 FSWs receiving PrEP at four client-friendly healthcare centers in Kinshasa in 2024, hereafter referred to as Clinic A, Clinic B, Clinic C, and Clinic D. Adherence was assessed using self-reported missed doses over the previous seven days and pill count. Retention in care was documented at months 3 and 6. Multivariable logistic regression guided by a directed acyclic graph (DAG) was used to identify factors associated with adherence at inclusion, month 3, and month 6. The median age of participants was 28 years (interquartile range [IQR]: 24-37). Based on pill count, adherence increased from 80.0% at inclusion to 93.6% at month 3 and 95.1% at month 6, whereas self-reported adherence declined over time. In DAG-informed models, clinic site was significantly associated with adherence at baseline. Compared with Clinic A, participants attending Clinic B (adjusted odds ratio [aOR] = 5.7; 95% confidence interval [CI]: 1.4-22.3) and Clinic C (aOR = 11.4; 95% CI: 2.1-61.1) were more likely to be adherent. No independent predictors were identified at later follow-up points. Retention in care was 92% at month 3 and 84% at month 6. PrEP adherence among FSWs in Kinshasa was high and improved over time when measured objectively. Baseline site-level differences underscore the importance of contextual and programmatic factors in supporting adherence. These findings provide evidence to inform the optimization and scale-up of PrEP delivery models for key populations in the DRC and similar settings.

  • Open Access

    Adherence to cholera prevention measures and associated factors among adults in three health zones of Kinshasa, Democratic Republic of the Congo

    by Ben Bepouka, Beni Matangi, Abed Nego Ndongosi

    Cholera remains a major public health concern in the Democratic Republic of the Congo (DRC), particularly in urban settings with limited access to safe wat

  • Simultaneous outbreaks of Ebola, cholera, mpox, and measles in DR Congo in 2025

    by Ben Bepouka, Mardoche Kafua, Beni Matangi, Murielle Longokolo, Hippolyte Situakibanza


  • Open Access

    Clinical Characteristics and Mortality Trends Among COVID-19 Patients During the First Four Waves in Ngaliema Clinic, Democratic Republic of the Congo

    by Ben Bepouka, Madone Mandina, Daniel Mvibudulu, Junior Matangila, Armand Okamba, Gertrude Muyeke, Dieudonne Tawaba, Nadine Mayasi, Ossam Odio, Donat Mangala, et al.

    Background: COVID-19 disease has been a deadly pandemic in different waves in the Democratic Republic of Congo. However, knowledge of the clinical characteristics of COVID-19 patients and the factors associated with death during different waves is important. Methods: We conducted a retrospective cohort of 410 patients hospitalized during 4 waves of COVID-19, from March 20, 2020, to January 2, 2022, at the Ngaliema clinic in DR Congo. We included any patient hospitalized for COVID-19 with biological confirmation by RT-PCR. Factors associated with death were investigated using logistic regression. Results: During the 4 waves of the COVID-19 pandemic at Clinique Ngaliema, complaints on admission were most often fever, cough and physical asthenia. Death was most common in the elderly, hypertensive and diabetic patients, those with elevated CRP and hyper leukocytosis. Mortality was highest in the 1st wave (28%), followed by the 3rd wave (27%), then the 2nd (22%) and 4th waves (21%). Factors associated with death were hyper leukocytosis (ORa: 2.76; CI 95%: 1.25– 6.1), severe disease stage (ORa 21.24; CI 95%: 1.87– 24). Vitamin C 500 mg twice a day use was protective (ORa: 0.24; CI 95%: 0.08– 0.72). Conclusion: COVID-19 disease poses a real public health problem, with non-negligible mortality. Factors associated with death were degree of disease severity, hyper leukocytosis and non-use of vitamin C. Taking these factors into account will help clinicians and decision-makers to anticipate future waves of the pandemic.

  • Open Access

    Treatment and case fatality rate of COVID-19 in Africa

    by Ben Bepouka, Patricia Bandubuila Kaja, Hippolyte Situakibanza

    In Africa, the treatment of COVID-19 depends on each country. Several protocols are observed with real results that we described in this study. The objective of this review was to describe the treatment of COVID-19 and the case fatality rate in African countries, by reviewing the literature on treatment and case fatality in African countries whose data was available through the internet during the writing period until February 7, 2021. The majority of African countries had a treatment based on hydroxychloroquine or chloroquine + azithromycin, used in varying doses depending on the country. The lethality in Africa remains low compared to European and American countries. The same treatment being used in some northern countries does not fully explain the low case fatality.


  • Open Access

    Risk factors for mortality in COVID-19 patients in sub-Saharan Africa: A systematic review and meta-analysis

    by Ben Bepouka, Nadine Mayasi, Madone Mandina, Murielle Longokolo, Ossam Odio, Donat Mangala, Marcel Mbula, Jean Marie Kayembe, Hippolyte Situakibanza

    Aim: Mortality rates of coronavirus-2019 (COVID-19) disease continue to increase worldwide and in Africa. In this study, we aimed to summarize the available results on the association between sociodemographic, clinical, biological, and comorbidity factors and the risk of mortality due to COVID-19 in sub-Saharan Africa.Methods: We followed the PRISMA checklist (S1 Checklist). We searched PubMed, Google Scholar, and European PMC between January 1, 2020, and September 23, 2021. We included observational studies with Subjects had to be laboratory-confirmed COVID-19 patients; had to report risk factors or predictors of mortality in COVID-19 patients, Studies had to be published in English, include multivariate analysis, and be conducted in the sub-Saharan region. Exclusion criteria included case reports, review articles, commentaries, errata, protocols, abstracts, reports, letters to the editor, and repeat studies. The methodological quality of the studies included in this meta-analysis was assessed using the methodological items for nonrandomized studies (MINORS). Pooled hazard ratios (HR) or odds ratios (OR) and 95% confidence intervals (CI) were calculated separately to identify mortality risk. In addition, publication bias and subgroup analysis were assessed.Results and discussion: Twelve studies with a total of 43598 patients met the inclusion criteria. The outcomes of interest were mortality. The results of the analysis showed that the pooled prevalence of mortality in COVID-19 patients was 4.8%. Older people showed an increased risk of mortality from SARS-Cov-2. The pooled hazard ratio (pHR) and odds ratio (pOR) were 9.01 (95% CI; 6.30–11.71) and 1.04 (95% CI; 1.02–1.06), respectively. A significant association was found between COVID-19 mortality and men (pOR = 1.52; 95% CI 1.04–2). In addition, the risk of mortality in patients hospitalized with COVID-19 infection was strongly influenced by chronic kidney disease (CKD), hypertension, severe or critical infection on admission, cough, and dyspnea. The major limitations of the present study are that the data in the meta-analysis came mainly from studies that were published, which may lead to publication bias, and that the causal relationship between risk factors and poor outcome in patients with COVID-19 cannot be confirmed because of the inherent limitations of the observational study.Conclusions: Advanced age, male sex, CKD, hypertension, severe or critical condition on admission, cough, and dyspnea are clinical risk factors for fatal outcomes associated with coronavirus. These findings could be used for research, control, and prevention of the disease and could help providers take appropriate measures and improve clinical outcomes in these patients.


  • Open Access

    Prevalence and Outcomes of COVID −19 Patients with Happy Hypoxia: A Systematic Review

    by Ben Bepouka, Ossam Odio, Nadine Mayasi, Murielle Longokolo, Donat Mangala, Madone Mandina, Marcel Mbula, Jean Marie Kayembe, Hippolyte Situakibanza

    Background: In Coronavirus disease 2019 (COVID-19), some patients have low oxygen saturation without any dyspnea. This has been termed “happy hypoxia.” No worldwide prevalence survey of this phenomenon has been conducted. This review aimed to summarize information on the prevalence, risk factors, and outcomes of patients with happy hypoxia to improve their management. Methods: We conducted a systematic search of electronic databases for all studies published up to April 30, 2022. We included high-quality studies using the Newcastle-Ottawa Scale (NOS) tool for qualitative assessment of searches. The prevalence of happy hypoxia, as well as the mortality rate of patients with happy hypoxia, were estimated by pooled analysis and heterogeneity by I2. Results: Of the 25,086 COVID-19 patients from the 7 studies, the prevalence of happy hypoxia ranged from 4.8 to 65%. The pooled prevalence was 6%. Happy hypoxia was associated with age > 65 years, male sex, body mass index (BMI)> 25 kg/m2, smoking, chronic obstructive pulmonary disease, diabetes mellitus, high respiratory rate, and high d-dimer. Mortality ranged from 01 to 45.4%. The pooled mortality was 2%. In 2 studies, patients with dyspnea were admitted to intensive care more often than those with happy hypoxia. One study reported that the length of stay in intensive care did not differ between patients with dyspnea and those with happy hypoxia at admission. One study reported the need for extracorporeal membrane oxygenation (ECMO) in patients with happy hypoxia. Conclusion: The pooled prevalence and mortality of patients with happy hypoxia were not very high. Happy hypoxia was associated with advanced age and comorbidities. Some patients were admitted to the intensive care unit, although fewer than dyspneic patients. Its early detection and management should improve the prognosis.


  • Open Access

    Diabetes Mellitus is Associated With Higher COVID-19 Mortality Rates in Sub-Saharan Africa: A Systematic Review and Meta-analysis

    by Ben Bepouka, Ossam Odio, Donat Mangala, Nadine Mayasi, Madone Mandina, Murielle Longokolo, Jean Robert Makulo, Marcel Mbula, Jean Marie Kayembe, Hippolyte Situakibanza

    The rate of COVID-19-related mortality among patients with diabetes mellitus in Sub-Saharan Africa (SSA) is unknown. The current study aimed to determine the mortality rate of COVID-19 among diabetes patients in SSA. We performed a systematic review of research articles until July 1, 2021. A literature review was conducted in accordance with the PRISMA guidelines to gather relevant data. A random effects model was used to calculate odds ratios and 95% confidence intervals (CIs). We used Egger's tests and Begg's funnel plot to examine publication bias. The mortality rate of 7778 COVID-19 patients was analyzed using data from seven studies. The I2 test was used to determine the heterogeneity between studies. The meta-analysis revealed that diabetes mellitus was linked to a 1.39-fold increase in the risk of death among COVID-19 inpatients (95% CI: 1.02-1.76). According to our findings, there was no significant heterogeneity between studies, and there was no publication bias. The present review describes an association between diabetes mellitus and the risk of COVID-19 mortality in SSA.